Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults
By J. Ludvigsson. Acta paediatrica, 2020
2,154 citations recorded by the source corpus.
The coronavirus disease 2019 (COVID‐19) pandemic has affected hundreds of thousands of people. Data on symptoms and prognosis in children are rare.
Subfields: Dermatology, Infectious Diseases, Obstetrics and Gynecology
View Paper: https://www.semanticscholar.org/paper/d73d87d6810a00d2136c95d5dd45816add78d5d1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Dermatology
In Infectious Diseases
In Obstetrics and Gynecology
Citations in the corpus
- Immune Response, Inflammation, and the Clinical Spectrum of COVID-19 (2020, background): “Ludvigsson (124) reviewed 45 publications on COVID-19 and found that 1–5% of the patients are children who, although they present with fever and respiratory symptoms, experience milder symptoms and among whom death was extremely rare.”
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia (2020, background): “The plasma levels of 31 molecular species was quanti fi ed using a Luminex platform (Human Cytokine Discovery, R&D System, Minneapolis, MN) for the simultaneous detection of the following molecules: IL-1 α , IL-1 β , IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, IL-13, IL-15, IL-17, gale”